Journal Article

Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizures

Nguyen, Malea, Or, Yvonne Yan Yan, MacPherson, Melissa J., Philippe, Christophe, Kesler, Mitchell, Innes, A. Micheil, Vasileiou, Georgia, Rackel, Brooke, Kurrasch, Deborah M., Theodorou, Evangelos, Ellis, James, Calame, Daniel G., Tran Mau-Them, Frederic, Ren, Yi, Keren, Boris, Steel, Edward, Hua, Michelle, Prouteau, Clément, Vitobello, Antonio, Dasouki, Majed J., Schuhmann, Sarah, Gafuik, Christopher J., Latner, Donald R., Cobben, Jan, Mahoney, Douglas J., Yang, Guang, Clark, Isabel, Wang, GengYi, Leventer, Richard J., Williams, Laura, Stark, Zornitza, Aghanoori, Mohamad-Reza, He, Guiqiong, Caylor, Raymond C., Duba-Kiss, Robert, Lichty, Angie, van Ierland, Yvette, Motazacker, Mahdi M., Isidor, Bertrand, Epp, Jonathan R., Bourgois, Alexia, McGillivray, George, Lakeman, Phillis, Teskey, G. Campbell, Quelin, Chloe, Tessarech, Marine, Prijoles, Eloise, Sweetser, David A., Cogné, Benjamin, Yang, Yifan, Ryan, Scott D., Siripala, Shehani V., Feng, Daniel

2026

Overview

De novo heterozygous variants in CUGBP Elav-like family member 2 ( CELF2 ) have recently been associated with a rare neurodevelopmental disorder, yet the mechanisms linking specific variants to distinct clinical phenotypes remain poorly understood. Here, we reported a cohort of 18 individuals and provided evidence that variants causing CELF2 mislocalization, but not protein-null variants, were associated with seizures. Using proband-derived human cortical neurons and transgenic mouse models, we demonstrated that CELF2 underwent activity-dependent nucleocytoplasmic shuttling in excitatory neurons and that its cytoplasmic retention caused neuronal hyperactivity, elevated seizure susceptibility, and learning and memory deficits. We further found that cytoplasmic CELF2 regulated mRNAs critical for synaptic function and neuronal excitability and implicated in epileptic seizures and intellectual disability. Drug screening further identified AKT signaling as a key regulator of CELF2 nucleocytoplasmic shuttling and a candidate target for reversing neuronal hyperactivity. Together, our findings expand the clinical and genetic spectrum of CELF2-related neurodevelopmental disorders and establish a variant-specific mechanism that links CELF2 mislocalization to neuronal hyperactivity, seizures, and cognitive impairment.

• Publisher: American Society for Clinical Investigation
• Subject: Animals / CELF Proteins - genetics / CELF Proteins - metabolism / Female / Humans / Learning Disabilities - genetics / Learning Disabilities - metabolism / Learning Disabilities - pathology / Male / Mice / Mice, Transgenic / Nerve Tissue Proteins - genetics / Nerve Tissue Proteins - metabolism / Neurons - metabolism / Neurons - pathology / Proto-Oncogene Proteins c-akt - genetics / Proto-Oncogene Proteins c-akt - metabolism / Seizures - genetics / Seizures - metabolism / Seizures - pathology